---
title: "Citius raises $36.5m for Lymphir commercialisation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285400494.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-05-06T12:04:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285400494.md)
  - [en](https://longbridge.com/en/news/285400494.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285400494.md)
---

# Citius raises $36.5m for Lymphir commercialisation

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [CTXR.US](https://longbridge.com/en/quote/CTXR.US.md)
- [CTOR.US](https://longbridge.com/en/quote/CTOR.US.md)

## Related News & Research

- [Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility](https://longbridge.com/en/news/285780539.md)
- [BUZZ-India's Cipla drops as US FDA urges action at key tumour drug supplier's facility](https://longbridge.com/en/news/276562451.md)
- [15:37 ETRunloop-Powered ION Launches to Make Vibe-coded Websites Win](https://longbridge.com/en/news/286811158.md)
- [19:23 ETSES Investors Have Opportunity to Lead SES AI Corporation Securities Fraud Lawsuit Filed by The Rosen Law Firm](https://longbridge.com/en/news/287129786.md)
- [08:50 ETShareholders who lost money in SES AI Corporation (NYSE: SES) Should Contact Wolf Haldenstein Immediately](https://longbridge.com/en/news/286773888.md)